An Observational, Non-interventional, Multi-national Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab.
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2014
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 19 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 19 May 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Jun 2014 to 1 Aug 2014.
- 27 Jan 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.